On June 6, British American Tobacco rose 3.03% in regular trading, trading at $59.67/share, with trading volume of $134 million. The rebound comes as the market digests positive signals from the company's new tobacco category business outperforming expectations.

A research note highlighted that British American Tobacco's H1 earnings preview showed new tobacco segment growth exceeding expectations. In vaporization, the company gained 1.3 percentage points of market share across core markets, with the U.S. market particularly strong at a 4.2-point share gain. The company indicated optimism around recent FDA policy developments and expects mid-single-digit growth for the overall segment in H1 and full year. Additionally, the company upgraded its new category revenue growth forecast to approximately 15%, up from a prior low-teens estimate.

The stock had declined over the prior sessions after the company cut its global cigarette industry volume forecast to a 2.5% year-over-year decline from approximately 2%, and maintained full-year guidance at the low end of its mid-term targets with revenue growth of 3%-5% and adjusted operating profit growth of 4%-6%. The current rebound reflects the market gradually pricing in the accelerating new category momentum offsetting traditional tobacco weakness.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)